Home › Funds › SECTORAL ASSET MANAGEMENT INC › CYTK

SECTORAL ASSET MANAGEMENT INC position in CYTK

CYTOKINETICS INC · Health Care

SECTORAL ASSET MANAGEMENT INC reported holding 15,289 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.75% of its reported portfolio and ranking #43 among its reported holdings. SECTORAL ASSET MANAGEMENT INC has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)15.29K sh
Reported value held$1.01M
Portfolio Weight0.75%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SECTORAL ASSET MANAGEMENT INC's CYTK position evolved

SECTORAL ASSET MANAGEMENT INC first disclosed a stake in CYTK in Q3 2023 at 118,303 shares (US$3.5M). Across 13 filings, SECTORAL ASSET MANAGEMENT INC increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 15,289 shares valued at US$1.0M — a reduction of -1,041 shares quarter over quarter.. Notable position changes include a 94% trim in Q4 2023 (shares fell 16% over the following quarter), a 507% increase in Q1 2024 (shares fell 23% over the following quarter), a 124% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 118.30K $3.49M New
Q4 2023 7.01K $585.51K Reduce
Q1 2024 42.58K $2.99M Add
Q2 2024 36.88K $2.00M Reduce
Q3 2024 28.59K $1.51M Reduce
Q4 2024 24.50K $1.15M Reduce
Q1 2025 18.07K $726.15K Reduce
Q2 2025 11.72K $387.33K Reduce
Q3 2025 10.22K $561.86K Reduce
Q4 2025 5.89K $374.44K Reduce
Q1 2026 7.30K $544.61K Add
Q2 2026 16.33K $1.39M Add
Q3 2026 15.29K $1.01M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 44 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has SECTORAL ASSET MANAGEMENT INC held CYTK?

SECTORAL ASSET MANAGEMENT INC has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SECTORAL ASSET MANAGEMENT INC's current position in CYTK?

As of Q3 2026, SECTORAL ASSET MANAGEMENT INC holds 15.29K shares of CYTK (CYTOKINETICS INC), valued at $1.01M, representing 0.75% of its reported portfolio and ranking #43.

Has SECTORAL ASSET MANAGEMENT INC been buying or selling CYTK?

In the latest 13F filing (Q3 2026), SECTORAL ASSET MANAGEMENT INC reduced its position in CYTK.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.